Search

Your search keyword '"MS Reumatologie/Immunologie/Infectie"' showing total 377 results

Search Constraints

Start Over You searched for: Author "MS Reumatologie/Immunologie/Infectie" Remove constraint Author: "MS Reumatologie/Immunologie/Infectie"
377 results on '"MS Reumatologie/Immunologie/Infectie"'

Search Results

1. Author Correction 2024: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z)

2. House dust mite sublingual allergen immunotherapy tablet is safe and well-tolerated in Dutch clinical practice

3. Myostatin and CXCL11 promote nervous tissue macrophages to maintain osteoarthritis pain

4. Does the impact of COVID-19 on patients with systemic sclerosis change over time?

5. Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study

6. Pulmonary Computed Tomography Screening Frequency in Primary Antibody Deficiency

7. Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer

8. Trends in body mass index in the pre-dolutegravir period in South Africa

9. The PID Odyssey 2030: outlooks, unmet needs, hurdles, and opportunities — proceedings from the IPOPI global multi-stakeholders’ summit (June 2022)

10. Chronische anemie en onverklaarde ontsteking

11. CCR9/CXCR5 Co-Expressing CD4 T Cells Are Increased in Primary Sjögren’s Syndrome and Are Enriched in PD-1/ICOS-Expressing Effector T Cells

12. Clinical Validation of a Primary Antibody Deficiency Screening Algorithm for Primary Care

13. Development and validation of a machine learning-supported strategy of patient selection for osteoarthritis clinical trials: the IMI-APPROACH study

14. Therapeutic drug monitoring of methotrexate in patients with Crohn's disease

15. Involvement of the systemic microcirculation in pediatric uveitis

16. JAK Inhibition with Baricitinib for Severe CVID-Related Enteropathy: a Case Report

17. Clinically Established Temporomandibular Involvement in Adults With Juvenile Idiopathic Arthritis

18. Endoscopic ultrasonography-guided gastroenterostomy versus surgical gastrojejunostomy for palliation of malignant gastric outlet obstruction (ENDURO): study protocol for a randomized controlled trial

19. Concomitant prednisone may alleviate methotrexate side-effects in rheumatoid arthritis patients

20. Subclinical synovial proliferation in patients with severe haemophilia A: The value of ultrasound screening and biochemical markers

21. Component Ana o 3 versus extract for cashew nut allergy: A diagnostic test accuracy study in adults

22. Association of endothelial to mesenchymal transition and cellular senescence with fibrosis in skin biopsies of systemic sclerosis patients: a cross-sectional study

23. Co-sensitization between legumes is frequently seen, but variable and not always clinically relevant

25. Anti-thymocyte globulin exposure in patients with diffuse cutaneous systemic sclerosis undergoing autologous haematopoietic stem cell transplantation

26. Identifying multivariate disease trajectories and potential phenotypes of early knee osteoarthritis in the CHECK cohort

27. What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis

28. A European-Japanese study on peach allergy: IgE to Pru p 7 associates with severity

29. Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response

30. Continuation of therapeutic dose heparin for critically ill patients with COVID-19

31. Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study

32. Systemic and Local Medical or Surgical Therapies for Ear, Nose and/or Throat Manifestations in ANCA-Associated Vasculitis: A Systematic Literature Review

33. Machine-learning predicted and actual 2-year structural progression in the IMI-APPROACH cohort

34. Prolonged Disease Course of COVID-19 in a Patient with CTLA-4 Haploinsufficiency

35. Development of a primary care screening algorithm for the early detection of patients at risk of primary antibody deficiency

36. Relevance of Biomarkers in Serum vs. Synovial Fluid in Patients with Knee Osteoarthritis

37. Structural changes after ankle joint distraction in haemophilic arthropathy: an explorative study investigating biochemical markers and 3D joint space width

38. Routine Lupus Anticoagulant Sensitive aPTT Testing Can Prevent Unnecessary LA Testing

39. Joint distraction using a purpose-built device for knee osteoarthritis: A prospective 2-year follow-up

40. The catabolic-to-anabolic shift seen in the canine osteoarthritic cartilage treated with knee joint distraction occurs after the distraction period

41. Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 Cohort

42. BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial

43. Management of systemic sclerosis: British Society for Rheumatology guideline scope

44. Point-of-care neutrophil CD64 as a rule in diagnostic test for bacterial infections in the emergency department

45. Prognostication of progressive pulmonary fibrosis in connective tissue disease-associated interstitial lung diseases: A cohort study

46. Exploring the differences between radiographic joint space width and MRI cartilage thickness changes using data from the IMI-APPROACH cohort

47. Emotion regulation and the salience network: a hypothetical integrative model of fibromyalgia

48. Artificial intelligence in osteoarthritis: Repair by knee joint distraction shows association of pain, radiographic and immunological outcomes

49. A meta-analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis

50. Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

Catalog

Books, media, physical & digital resources